Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein e-knockout mice by alleviating inflammation and endothelial dysfunction

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 30, Issue 4, 2010, Pages 749-757

  Loke, Wai Mun ^a,b   Proudfoot, Julie M ^a   Hodgson, Jonathan M ^a   McKinley, Allan J ^b   Hime, Neil ^c   Magat, Maria ^c   Stocker, Roland ^c   Croft, Kevin D ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Endothelial dysfunction; Endothelin 1; Inflammation; NO; Oxidative stress; Polyphenol; Soluble P selectin

Indexed keywords

APOLIPOPROTEIN E; CHLOROGENIC ACID; CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPICATECHIN; FATTY ACID; HEME OXYGENASE 1; LEUKOTRIENE B4; PADGEM PROTEIN; POLYPHENOL; QUERCETIN; SESAMIN; SUPEROXIDE; THEAFLAVIN; 1,3 DIOXOLANE DERIVATIVE; ANTIINFLAMMATORY AGENT; BIFLAVONOID; BIOLOGICAL MARKER; CATECHIN; ENDOTHELIN 1; FLAVONOID; HMOX1 PROTEIN, MOUSE; ISOPROSTANE DERIVATIVE; LIGNAN; MEMBRANE PROTEIN; NITRATE; NITRIC OXIDE; NITRITE; NOS3 PROTEIN, MOUSE; PHENOL DERIVATIVE; POLYPHENOLS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA SINUS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CHEMICAL STRUCTURE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOLOGY; INFLAMMATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PLASMA; PRIORITY JOURNAL; THORACIC AORTA; ANIMAL; AORTA; AORTA DISEASE; BLOOD; C57BL MOUSE; DISEASE MODEL; DRUG EFFECT; GENETICS; MALE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; URINE; VASCULAR ENDOTHELIUM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; AORTA; AORTIC DISEASES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BIFLAVONOIDS; BIOLOGICAL MARKERS; CATECHIN; CHLOROGENIC ACID; CHOLESTEROL; DIET; DIOXOLES; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; F2-ISOPROSTANES; FATTY ACIDS; FLAVONOIDS; HEME OXYGENASE-1; INFLAMMATION; LEUKOTRIENE B4; LIGNANS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; OXIDATIVE STRESS; P-SELECTIN; PHENOLS; QUERCETIN; SUPEROXIDES;

EID: 77950902298     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.109.199687     Document Type: Article

References (63)

1. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-874.
2. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004;84:1381-1478.
3. Mano T, Masuyama T, Yamamoto K, Naito J, Kondo H, Nagano R, Tanouchi J, Hori M, Inoue M, Kamada T. Endothelial dysfunction in the early stage of atherosclerosis precedes appearance of intimal lesions assessable with intravascular ultrasound. Am Heart J. 1996;131:231-238.
4. Huxley RR, Neil HAW. The relation between dietary flavonol intake and coronary heart disease mortality: a meta-analysis of prospective cohort studies. Eur J Clin Nutr. 2003;57:904-908.
5. Geleijnse JM, Launer LJ, van der Kuip DA, Hofman A, Witteman JC. Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr. 2002;75:880-886.
6. Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA. Tea consumption and mortality after acute myocardial infarction. Circulation. 2002;105:2476-2481.
7. Castilla P, Echarri R, Davalos A, Cerrato F, Ortega H, Teruel JL, Lucas MF, Gomez-Coronado D, Ortuno J, Lasuncion MA. Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects. Am J Clin Nutr. 2006;84:252-262.
8. Zern TL, Wood RJ, Greene C, West KL, Liu Y, Aggarwal D, Shachter NS, Fernandez ML. Grape polyphenols exert a cardioprotective effect in pre-and postmenopausal women by lowering plasma lipids and reducing oxidative stress. J Nutr. 2005;135:1911-1917.
9. Schroeter H, Heiss C, Balzer J, Kleinbongard P, Keen CL, Hollenberg NK, Sies H, Kwik-Uribe C, Schmitz HH, Kelm M. (\)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci USA. 2006;103:1024-1029.
10. Widlansky ME, Duffy SJ, Hamburg NM, Gokce N, Warden BA, Wiseman S, Keaney JF Jr, Frei B, Vita JA. Effects of black tea consumption on plasma catechins and markers of oxidative stress and inflammation in patients with coronary artery disease. Free Radic Biol Med. 2005;38:499-506.
11. Duffy SJ, Keaney JF Jr, Holbrook M, Gokce N, Swerdloff PL, Frei B, Vita JA. Short-and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation. 2001; 104:151-156. (Pubitemid 32655830)
12. Nijveldt RJ, van Nood E, van Hoorn DEC, Boelens PG, van Norren K, van Leeuwen PAM. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr. 2001;74:418-425.
13. Sanchez M, Lodi F, Vera R, Villar IC, Cogolludo A, Jimenez R, Moreno L, Romero M, Tamargo J, Perez-Vizcaino F, Duarte J. Quercetin and isorhamnetin prevent endothelial dysfunction, superoxide production, and overexpression of p47phox induced by angiotensin II in rat aorta. J Nutr. 2007;137:910-915.
14. Loke WM, Hodgson JM, Proudfoot JM, McKinley AJ, Puddey IB, Croft KD. Pure dietary flavonoids quercetin and (\)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am J Clin Nutr. 2008;88:1018-1025.
15. Loke WM, Proudfoot JM, Stewart S, McKinley AJ, Needs PW, Kroon PA, Hodgson JM, Croft KD. Metabolic transformation has a profound effect on anti-inflammatory activity of flavonoids such as quercetin: lack of association between antioxidant and lipoxygenase inhibitory activity. Biochem Pharmacol. 2008;75:1045-1053.
16. Leung LK, Su Y, Chen R, Zhang Z, Huang Y, Chen Z-Y. Theaflavins in black tea and catechins in green tea are equally effective antioxidants. J Nutr. 2001;131:2248-2251.
17. Wu W-H, Kang Y-P, Wang N-H, Jou H-J, Wang T-A. Sesame ingestion affects sex hormones, antioxidant status, and blood lipids in postmenopausal women. J Nutr. 2006;136:1270-1275.
18. Morton LW, Caccetta RA, Puddey IB, Croft KD. Chemistry and biological effects of dietary phenolic compounds: relevance to cardiovascular disease. Clin Exp Pharmacol Physiol. 2000;27:152-159.
19. Manach C, Williamson G, Morand C, Scalbert A, Remesy C. Bioavailability and bioefficacy of polyphenols in humans, I: review of 97 bioavailability studies. Am J Clin Nutr. 2005;81(suppl):230S-242S.
20. Ings RMJ. Interspecies scaling and comparisons in drug development and toxicokinetics. Xenobiotica. 1990;20:1201-1231.
21. Waddington E, Puddey IB, Croft KD. Red wine polyphenolic compounds inhibit atherosclerosis in apolipoprotein E-deficient mice independently of effects on lipid peroxidation. Am J Clin Nutr. 2004;79:54-61.
22. Stocker R, O'Halloran RA. Dealcoholized red wine decreases atherosclerosis in apolipoprotein E gene-deficient mice independently of inhibition of lipid peroxidation in the artery wall. Am J Clin Nutr. 2004;79:123-130.
23. Mori TA, Croft KD, Puddey IB, Beilin LJ. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chroma-tography-mass spectrometry. Anal Biochem. 1999;268:117-125.
24. Ng DS, Maguire GF, Wylie J, Ravandi A, Xuan W, Ahmed Z, Eskan-darian M, Kuksis A, Connelly PW. Oxidative stress is markedly elevated in lecithin:cholesterol acyltransferase-deficient mice and is paradoxically reversed in the apolipoprotein e knockout background in association with a reduction in atherosclerosis. J Biol Chem. 2002;277:11715-11720.
25. Tsikas D. Simultaneous derivatization and quantification of the nitric oxide metabolites nitrite and nitrate in biological fluids by gas chroma-tography/mass spectrometry. Anal Chem. 2000;72:4064-4072.
26. Townend J. Analysis of Variance: Practical Statistics for Environmental and Biological Scientists. Hoboken, NJ: J Wiley & Sons; 2002.
27. Miura Y, Chiba T, Tomita I, Koizumi H, Miura S, Umegaki K, Hara Y, Ikeda M, Tomita T. Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J Nutr. 2001;131:27-32.
28. Hishikawa K, Nakaki T, Fujita T. Oral flavonoid supplementation attenuates atherosclerosis development in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2005;25:442-446.
29. Hayek T, Fuhrman B, Vaya J, Rosenblat M, Belinky P, Coleman R, Elis A, Aviram M. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler Thromb Vasc Biol. 1997;17: 2744-2752.
30. Kawai Y, Nishikawa T, Shiba Y, Saito S, Murota K, Shibata N, Kobayashi M, Kanayama M, Uchida K, Terao J. Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: implication in the anti-atherosclerotic mechanism of dietary flavonoids. J Biol Chem. 2008;283:9424-9434.
31. Tijburg LB, Wiseman SA, Meijer GW, Weststrate JA. Effects of green tea, black tea and dietary lipophilic antioxidants on LDL oxidizability and atherosclerosis in hypercholesterolaemic rabbits. Atherosclerosis. 1997; 135:37-47.
32. Nardini M, Pisu P, Gentili V, Natella F, Di Felice M, Piccolella E, Scaccini C. Effect of caffeic acid on tert-butyl hydroperoxide-induced oxidative stress in U937. Free Radic Biol Med. 1998;25:1098-1105.
33. Natella F, Nardini M, Belelli F, Scaccini C. Coffee drinking induces incorporation of phenolic acids into LDL and increases the resistance of LDL to ex vivo oxidation in humans. Am J Clin Nutr. 2007;86:604-609.
34. Witting P, Pettersson K, Ostlund-Lindqvist AM, Westerlund C, Wagberg M, Stocker R. Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbits. J Clin Invest. 1999;104:213-220.
35. Choy K, Beck K, Png FY, Wu BJ, Leichtweis SB, Thomas SR, Hou JY, Croft KD, Mori TA, Stocker R. Processes involved in the site-specific effect of probucol on atherosclerosis in apolipoprotein E gene knockout mice. Arterioscler Thromb Vasc Biol. 2005;25:1684-1690.
36. Davies MJ, Judd JT, Baer DJ, Clevidence BA, Paul DR, Edwards AJ, Wiseman SA, Muesing RA, Chen SC. Black tea consumption reduces total and LDL cholesterol in mildly hypercholesterolemic adults. J Nutr. 2003;133:3298S-3302S.
37. Chironi G, Dosquet C, Del-Pino M, Denarie N, Megnien J-L, Drouet L, Bal dit Sollier C, Levenson J, Simon A. Relationship of circulating biomarkers of inflammation and hemostasis with preclinical atherosclerotic burden in nonsmoking hypercholesterolemic men. Am J Hypertens. 2006;19:1025-1031.
38. Davi G, Romano M, Mezzetti A, Procopio A, Iacobelli S, Antidormi T, Bucciarelli T, Alessandrini P, Cuccurullo F, Bon GB. Increased levels of soluble P-selectin in hypercholesterolemic patients. Circulation. 1998;97: 953-957.
39. Varughese GI, Patel JV, Tomson J, Blann AD, Hughes EA, Lip GY. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial. J Intern Med. 2007;261:384-391.
40. Dong ZM, Brown AA, Wagner DD. Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. Circulation. 2000;101:2290-2295.
41. Jala VR, Haribabu B. Leukotrienes and atherosclerosis: new roles for old mediators. Trends Immunol. 2004;25:315-322.
42. Back M, Bu D-X, Branstrom R, Sheikine Y, Yan Z-Q, Hansson GK. Leukotriene B4 signaling through NF-KB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia. Proc Natl Acad Sci USA. 2005;102:17501-17506.
43. Subbarao K, Jala VR, Mathis S, Suttles J, Zacharias W, Ahamed J, Ali H, Tseng MT, Haribabu B. Role of leukotriene B4 receptors in the development of atherosclerosis: potential mechanisms. Arterioscler Thromb Vasc Biol. 2004;24:369-375.
44. Sanbongi C, Suzuki N, Sakane T. Polyphenols in chocolate, which have antioxidant activity, modulate immune functions in humans in-vitro. Cell Immunol. 1997;177:129-136.
45. Huang MT, Liu Y, Ramji D, Lo CY, Ghai G, Dushenkov S, Ho CT. Inhibitory effects of black tea theaflavin derivatives on 12-tetradecanoyl-phorbol-13- acetate-induced inflammation and arachidonic acid metabolism in mouse ears. Mol Nutr Food Res. 2006;50:115-122.
46. Jeng KC, Hou RC, Wang JC, Ping LI. Sesamin inhibits lipopolysaccha-ride- induced cytokine production by suppression of p38 mitogen-acti-vated protein kinase and nuclear factor-kappaB. Immunol Lett. 2005;97: 101-106.
47. Feng R, Lu Y, Bowman LL, Qian Y, Castranova V, Ding M. Inhibition of activator protein-1, NF-kB, and MAPKS and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J Biol Chem. 2005;280: 27888-27895.
48. Kinlay S, Libby P, Ganz P. Endothelial function and coronary artery disease. Curr Opin Lipidol. 2001;12:383-389.
49. Papamichael C, Karatzis E, Karatzi K, Aznaouridis K, Papaioannou T, Protogerou A, Stamatelopoulos K, Zampelas A, Lekakis J, Mavrikakis M. Red wine's antioxidants counteract acute endothelial dysfunction caused by cigarette smoking in healthy nonsmokers. Am Heart J. 2004;147:274.
50. Hodgson JM. Effects of tea and tea flavonoids on endothelial function and blood pressure: a brief review. Clin Exp Pharmacol Physiol. 2006;33: 838-841.
51. Sanchez M, Galisteo M, Vera R, Villar IC, Zarzuelo A, Tamargo J, Perez-Vizcaino F, Duarte J. Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. J Hypertens. 2006;24:75-84.
52. Steffen Y, Schewe T, Sies H. (\)-Epicatechin elevates nitric oxide in endothelial cells via inhibition of NADPH oxidase. Biochem Biophys Res Comm. 2007;359:828-833.
53. Barton M, Haudenschild CC, d'Uscio LV, Shaw S, Münter K, Lüscher TF. Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Proc Natl Acad Sci USA. 1998;95:14367-14372.
54. Stocker R, Perrella MA. Heme oxygenase-1: a novel drug target for atherosclerotic diseases? Circulation. 2006;114:2178-2189.
55. Wu BJ, Kathir K, Witting PK, Beck K, Choy K, Li C, Croft KD, Mori TA, Tanous D, Adams MR. Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging. J Exp Med. 2006;203:1117-1127.
56. Ishikawa K, Sugawara D, Wang X-P, Suzuki K, Itabe H, Maruyama Y, Lusis AJ. Heme oxygenase-1 inhibits atherosclerotic lesion formation in LDL-receptor knockout mice. Circ Res. 2001;88:506-512.
57. Ishikawa K, Sugawara D, Goto J, Watanabe Y, Kawamura K, Shiomi M, Itabe H, Maruyama Y. Heme oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits. Circulation. 2001;104: 1831-1836.
58. Juan S-H, Lee T-S, Tseng K-W, Liou J-Y, Shyue S-K, Wu KK, Chau L-Y. Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2001;104:1519-1525.
59. Motterlini R, Foresti R, Bassi R, Green CJ. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med. 2000;28: 1303-1312.
60. Juan S-H, Cheng T-H, Lin H-C, Chu Y-L, Lee W-S. Mechanism of concentration-dependent induction of heme oxygenase-1 by resveratrol in human aortic smooth muscle cells. Biochem Pharmacol. 2005;69:41-48.
61. Ryter SW, Alam J, Choi AMK. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev. 2006;86: 583-650.
62. Witting PK, Wu BJ, Raftery M, Southwell-Keely P, Stocker R. Probucol protects against hypochlorite-induced endothelial dysfunction. J Biol Chem. 2005;280:15612-15618.
63. Motterlini R, Foresti R, Intaglietta M, Winslow RM. NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Am J Physiol Heart Circ Physiol. 1996;270: H107-H114.